ABOS
Price
$1.13
Change
+$0.02 (+1.80%)
Updated
Jul 2 closing price
Capitalization
68.75M
46 days until earnings call
GBIO
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Jul 2 closing price
Capitalization
22.65M
34 days until earnings call
Interact to see
Advertisement

ABOS vs GBIO

Header iconABOS vs GBIO Comparison
Open Charts ABOS vs GBIOBanner chart's image
Acumen Pharmaceuticals
Price$1.13
Change+$0.02 (+1.80%)
Volume$167.33K
Capitalization68.75M
Generation Bio
Price$0.34
Change+$0.02 (+6.25%)
Volume$696.32K
Capitalization22.65M
ABOS vs GBIO Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. GBIO commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and GBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ABOS: $1.13 vs. GBIO: $0.34)
Brand notoriety: ABOS and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 47% vs. GBIO: 92%
Market capitalization -- ABOS: $68.75M vs. GBIO: $22.65M
ABOS [@Biotechnology] is valued at $68.75M. GBIO’s [@Biotechnology] market capitalization is $22.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ABOS is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while GBIO’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 5 bearish.
  • GBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than GBIO.

Price Growth

ABOS (@Biotechnology) experienced а -7.72% price change this week, while GBIO (@Biotechnology) price change was -7.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

GBIO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($68.8M) has a higher market cap than GBIO($22.7M). ABOS YTD gains are higher at: -34.012 vs. GBIO (-68.123). GBIO has higher annual earnings (EBITDA): -69.2M vs. ABOS (-111.98M). GBIO has more cash in the bank: 158M vs. ABOS (149M). ABOS has less debt than GBIO: ABOS (29M) vs GBIO (87.6M). GBIO has higher revenues than ABOS: GBIO (24.6M) vs ABOS (0).
ABOSGBIOABOS / GBIO
Capitalization68.8M22.7M303%
EBITDA-111.98M-69.2M162%
Gain YTD-34.012-68.12350%
P/E RatioN/AN/A-
Revenue024.6M-
Total Cash149M158M94%
Total Debt29M87.6M33%
TECHNICAL ANALYSIS
Technical Analysis
ABOSGBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDRRF0.390.01
+3.35%
TUDOR GOLD CORP NEW
CMSQY26.320.31
+1.18%
Computershare Ltd.
SCGPY2.78N/A
N/A
Serco Group Plc.
WFCNP1.50N/A
N/A
Wells Fargo & Co.
FGCO0.17-0.02
-8.33%
Financial Gravity Companies, Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+2.25%
FHTX - ABOS
54%
Loosely correlated
+2.26%
CRBU - ABOS
54%
Loosely correlated
+9.20%
BEAM - ABOS
50%
Loosely correlated
+13.46%
IPSC - ABOS
50%
Loosely correlated
+2.21%
CRSP - ABOS
49%
Loosely correlated
+6.51%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+5.59%
CCCC - GBIO
50%
Loosely correlated
+0.66%
ATXS - GBIO
49%
Loosely correlated
+5.52%
IDYA - GBIO
48%
Loosely correlated
+3.79%
FHTX - GBIO
48%
Loosely correlated
+2.26%
ATNM - GBIO
47%
Loosely correlated
+5.93%
More